Santen Pharmaceutical Co Ltd
TSE:4536
Santen Pharmaceutical Co Ltd
TSE:4536
Price:
1 598 JPY
-0.34%
Market Closed
Updated:
May 17, 2024
Santen Pharmaceutical Co Ltd
Depreciation & Amortization
|
Santen Pharmaceutical Co Ltd
Depreciation & Amortization Peer Comparison
Comparables:
4502
4568
4578
4519
4503
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Santen Pharmaceutical Co Ltd
TSE:4536
|
Depreciation & Amortization
-¥11.7B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-30%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Depreciation & Amortization
-¥652.1B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-16%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Astellas Pharma Inc
TSE:4503
|
Depreciation & Amortization
-¥98.8B
|
CAGR 3-Years
-61%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-11%
|
See Also
What is Santen Pharmaceutical Co Ltd's Depreciation & Amortization?
Depreciation & Amortization
-11.7B
JPY
-11.7B
JPY
Based on the financial report for Mar 31, 2024, Santen Pharmaceutical Co Ltd's Depreciation & Amortization amounts to -11.7B JPY.
What is Santen Pharmaceutical Co Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
-30%
-30%
Over the last year, the Depreciation & Amortization growth was -23%. The average annual Depreciation & Amortization growth rates for Santen Pharmaceutical Co Ltd have been -3% over the past three years , -11% over the past five years , and -30% over the past ten years .
You don't have any saved screeners yet
